摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methylthioethanol | 84418-46-2

中文名称
——
中文别名
——
英文名称
methylthioethanol
英文别名
1-(Methylthio)ethanol;1-methylsulfanylethanol
methylthioethanol化学式
CAS
84418-46-2
化学式
C3H8OS
mdl
——
分子量
92.1619
InChiKey
CRNYSFZMDKIGQU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    5
  • 可旋转键数:
    1
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    45.5
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    methylthioethanol 为溶剂, 生成 甲硫醇乙醛
    参考文献:
    名称:
    Solvent effects on equilibria of addition of nucleophiles to acetaldehyde and the hydrophilic character of diols
    摘要:
    DOI:
    10.1021/ja00343a044
  • 作为产物:
    描述:
    甲硫醇乙醛 为溶剂, 生成 methylthioethanol
    参考文献:
    名称:
    Solvent effects on equilibria of addition of nucleophiles to acetaldehyde and the hydrophilic character of diols
    摘要:
    DOI:
    10.1021/ja00343a044
点击查看最新优质反应信息

文献信息

  • Thiazole derivatives
    申请人:Takeda Chemical Industries, Ltd.
    公开号:US04695639A1
    公开(公告)日:1987-09-22
    A novel aminothiazoleacetic acid derivative which is an advantageous synthetic intermediate for .beta.-lactam antibiotics, and its production method and use. Starting with diketene, the production method comprises the following squence of steps. ##STR1## (In the above formulas, R is lower alkyl or phenyl; R.sub.1 and R.sub.2 each are hydrogen or lower alkyl; X and X' each are halogen; W is S or SO.sub.2 ; and W' is OH or ##STR2##
    一种新型的氨基噻唑乙酸衍生物,是β-内酰胺类抗生素的有利合成中间体,以及其生产方法和用途。生产方法以二羰基为起始物,包括以下步骤: ##STR1## (在上述公式中,R为低碳基或苯基;R1和R2各为氢或低碳基;X和X'各为卤素;W为S或SO2;W'为OH或##STR2##)
  • N-phenylpyrazole derivatives as pesticides
    申请人:Schnatterer Stefan
    公开号:US20070281987A1
    公开(公告)日:2007-12-06
    The invention relates to polar 5-aminopyrazole carbamate derivatives of formula (I) or salts thereof: (I), wherein the various symbols are as defined in the description, to processes for their preparation, to compositions thereof, and to their use for the control of pests (including arthropods and helminths).
    本发明涉及公式(I)的极性5-氨基吡唑氨基甲酸酯衍生物或其盐:(I),其中各符号如描述中所定义,以及它们的制备方法、组合物和用于控制害虫(包括节肢动物和蠕虫)的用途。
  • GLUCOKINASE ACTIVATOR
    申请人:Fukuda Yasumichi
    公开号:US20100099671A1
    公开(公告)日:2010-04-22
    A compound, or a pharmaceutically acceptable salt thereof, represented by the formula (1), (wherein, the carbon atom marked with an * is in the R-configuration, R 1 represents a hydrogen atom, a halogen atom, an amino group, a hydroxyl group, a hydroxyamino group, a nitro group, a cyano group, a sulfamoyl group, a C 1 -C 6 alkyl group, or a C 1 -C 6 alkoxy group, R 2 represents a C 3 -C 6 cycloalkylsulfanyl group, a C 3 -C 6 cycloalkylsulfinyl group, or a C 3 -C 6 cycloalkylsulfonyl group, and A represents a substituted or unsubstituted heteroaryl group).
    化合物或其药学上可接受的盐,其化学式表示为(1),其中标有*的碳原子为R构型,R1表示氢原子、卤素原子、氨基、羟基、羟氨基、硝基、氰基、磺酰基、C1-C6烷基或C1-C6烷氧基,R2表示C3-C6环烷基磺基、C3-C6环烷基亚磺基或C3-C6环烷基磺酰基,A表示取代或未取代的杂环芳基。
  • CYCLOPENTYLACRYLAMIDE DERIVATIVE
    申请人:Fukuda Yasumichi
    公开号:US20110160211A1
    公开(公告)日:2011-06-30
    A compound having a hypoglycemic effect is provided. The compound and a pharmaceutically acceptable salt thereof are useful for the treatment or prevention of diabetes, obesity, and the like. The compound is represented by the general formula (1): (wherein R 1 and R 2 are each independently a hydrogen atom, a halogen atom, an amino group, a hydroxyl group, a hydroxyamino group, a nitro group, a cyano group, a sulfamoyl group, a C 1 to C 6 alkyl group, a C 1 to C 6 alkoxy group, a C 1 to C 6 alkylsulfanyl group, a C 1 to C 6 alkylsulfinyl group, a C 1 to C 6 alkylsulfonyl group, or a C 1 to C 6 alkoxy-C 1 to C 6 alkylsulfonyl group, and A is a substituted or unsubstituted heteroaryl group).
    提供了一种具有降血糖作用的化合物。该化合物及其药学上可接受的盐可用于治疗或预防糖尿病、肥胖症等疾病。该化合物由一般式(1)表示:(其中R1和R2分别独立地为氢原子、卤素原子、氨基、羟基、羟基氨基、硝基、氰基、磺酰基、C1到C6烷基、C1到C6烷氧基、C1到C6烷基硫基、C1到C6烷基亚砜基、C1到C6烷基磺酰基或C1到C6烷氧基-C1到C6烷基磺酰基;A为取代或未取代的杂环芳基)。
  • Glucokinase activator
    申请人:Kyorin Pharmaceutical Co., Ltd.
    公开号:US08034819B2
    公开(公告)日:2011-10-11
    A compound, or a pharmaceutically acceptable salt thereof, represented by the formula (1), (wherein, the carbon atom marked with an * is in the R-configuration, R1 represents a hydrogen atom, a halogen atom, an amino group, a hydroxyl group, a hydroxyamino group, a nitro group, a cyano group, a sulfamoyl group, a C1-C6 alkyl group, or a C1-C6 alkoxy group, R2 represents a C3-C6 cycloalkylsulfanyl group, a C3-C6 cycloalkylsulfinyl group, or a C3-C6 cycloalkylsulfonyl group, and A represents a substituted or unsubstituted heteroaryl group).
    一个化合物,或其药学上可接受的盐,由公式(1)表示,其中,标有*的碳原子处于R构型,R1代表氢原子、卤原子、氨基、羟基、羟基氨基、硝基、氰基、磺酰氨基、C1-C6烷基或C1-C6烷氧基,R2代表C3-C6环烷基磺基、C3-C6环烷基亚砜基或C3-C6环烷基磺酰基,A代表取代或未取代的杂环芳基。
查看更多